Effects of glucagon-like peptide-I on glucose turnover in rats

被引:21
|
作者
VanDijk, G
Lindskog, S
Holst, JJ
Steffens, AB
Ahren, B
机构
[1] LUND UNIV, DEPT MED, S-20502 MALMO, SWEDEN
[2] UNIV COPENHAGEN, DEPT MED PHYSIOL, DK-2200 COPENHAGEN, DENMARK
[3] UNIV GRONINGEN, DEPT ANIM PHYSIOL, 9750 AA HAREN, NETHERLANDS
关键词
insulin secretion; glucagon secretion; tritiated glucose; fasting;
D O I
10.1152/ajpendo.1996.270.6.E1015
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The influences of glucagon-like peptide-I-(7-36) amide (GLP-I; 15 pmol . kg(-1). min(-1)) on glucose turnover were studied in freely moving Wistar rats. In fed rats, GLP-I reduced plasma glucose (from 7.3 +/- 0.2 to 5.6 +/- 0.3 mmol/l; P = 0.017), increased plasma insulin (from 20 +/- 3 to 89 +/- 11 mU/l; P = 0.002), and reduced plasma glucagon (from 44 +/- 1 to 35 +/- 2 pg/ml; P = 0.009) and glucose appearance rate (R(a); from 3.9 1 0.2 to 1.7 +/- 0.7 mu mol . min(-1). 100 g(-1) after 30 min; P = 0.049) without affecting glucose disappearance rate (R(d)). The glucose clearance rate (MCR) was increased (P = 0.048). In 48-h-fasted rats, GLP-I reduced plasma glucose (from 5.0 +/- 0.2 to 4.4 +/- 0.3 mmol/l; P = 0.035) and increased plasma insulin (from 4 +/- 1 to 25 +/- 10 mU/l; P = 0.042) and plasma glucagon (from 43 +/- 3 to 61 +/- 7 pg/ml; P = 0.046). R(a) and R(d) were not significantly affected, although R(a) was lower than R(d) after 15-30 min (P = 0.005) and MCR was increased (P = 0.049). Thus GLP-I reduces R(a) in fed rats and increases MCR in fed and fasted rats. The reduced R(a) seems mediated by an increased insulin-to-glucagon ratio; the increased glucose clearance seems dependent on insulin and a peripheral effect of GLP-I.
引用
收藏
页码:E1015 / E1021
页数:7
相关论文
共 50 条
  • [1] Effects of glucagon-like peptide-I (GLP-I) on glucose homeostasis and food intake
    Balkan, B
    [J]. APPETITE, 2000, 35 (03) : 269 - 270
  • [2] DISCUSSING THE ROLE OF GLUCAGON-LIKE PEPTIDE-I
    HOLST, JJ
    ORSKOV, C
    [J]. DIABETES CARE, 1992, 15 (10) : 1440 - 1441
  • [3] DISCUSSING THE ROLE OF GLUCAGON-LIKE PEPTIDE-I - REPLY
    NATHAN, DM
    HABENER, JF
    [J]. DIABETES CARE, 1992, 15 (10) : 1441 - 1441
  • [4] Structure-activity relationship of glucagon-like peptide-I
    Goke, R
    Hoffmann, E
    Vahl, T
    Bode, HP
    Hareter, A
    Goke, B
    [J]. DIABETES, 1996, 45 : 1276 - 1276
  • [5] DOES GLUCAGON-LIKE PEPTIDE-I AFFECT THE CATABOLIC EFFECTS OF GLUCAGON IN THE INSULIN DEFICIENT STATE
    FREYSE, EJ
    KNOSPE, S
    ELHAG, O
    BECHER, T
    FISCHER, U
    GOKE, B
    [J]. DIABETOLOGIA, 1995, 38 : A167 - A167
  • [6] Calcium mobilization by glucagon-like peptide-I in pancreatic β-cells
    Wakui, M
    Suga, S
    Kanno, T
    Kamimura, N
    [J]. DYNAMIC CELLS: CELL BIOLOGY OF THE 21ST CENTURY, 1998, 1166 : 145 - 153
  • [7] Association of Pancreatitis with Glucagon-Like Peptide-I Agonist Use
    Anderson, Sarah L.
    Trujillo, Jennifer M.
    [J]. ANNALS OF PHARMACOTHERAPY, 2010, 44 (05) : 904 - 909
  • [8] STRUCTURAL REQUIREMENTS FOR BIOLOGICAL-ACTIVITY OF GLUCAGON-LIKE PEPTIDE-I
    MOJSOV, S
    [J]. INTERNATIONAL JOURNAL OF PEPTIDE AND PROTEIN RESEARCH, 1992, 40 (3-4): : 333 - 343
  • [9] GLUCAGON-LIKE PEPTIDE-I REDUCES POSTPRANDIAL GLYCEMIC EXCURSIONS IN IDDM
    DUPRE, J
    BEHME, MT
    HRAMIAK, IM
    MCFARLANE, P
    WILLIAMSON, MP
    ZABEL, P
    MCDONALD, TJ
    [J]. DIABETES, 1995, 44 (06) : 626 - 630
  • [10] GLUCAGON-LIKE PEPTIDE-I (7-37) ACTIONS ON ENDOCRINE PANCREAS
    WEIR, GC
    MOJSOV, S
    HENDRICK, GK
    HABENER, JF
    [J]. DIABETES, 1989, 38 (03) : 338 - 342